Strong Q1 On Good Product Mix: Biocon
  • Saba Ashraf
  • Jul 26 2013

July 26: After posting a good set of earnings numbers, Biocon Chairman and MD Kiran Mazumdar Shaw says the company’s good product mix, led by the insulin business, has fuelled growth in the first quarter. The research services business also grew 26% in Q1, she adds.